S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
pixel
S&P 500   3,768.47
DOW   30,924.14
QQQ   304.10
pixel
pixel
pixel
Log in
NASDAQ:BCRX

BioCryst Pharmaceuticals Price Target, Predictions & Analyst Ratings

$10.92
-0.95 (-8.00 %)
(As of 03/4/2021 12:00 AM ET)
Add
Compare
Today's Range
$10.78
Now: $10.92
$12.01
50-Day Range
$8.15
MA: $9.92
$11.98
52-Week Range
$1.58
Now: $10.92
$12.90
Volume8.17 million shs
Average Volume7.17 million shs
Market Capitalization$1.94 billion
P/E RatioN/A
Dividend YieldN/A
Beta3.03

Analyst Ratings

BioCryst Pharmaceuticals (NASDAQ:BCRX) Price Target and Consensus Rating

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
11 Wall Street analysts have issued ratings and price targets for BioCryst Pharmaceuticals in the last 12 months. Their average twelve-month price target is $11.38, predicting that the stock has a possible upside of 4.17%. The high price target for BCRX is $16.00 and the low price target for BCRX is $6.00. There are currently 3 hold ratings and 8 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
BCRX Consensus Rating: BuyBuyBuyBuy
BCRX Consensus Rating Score: 2.732.702.702.63
BCRX Analyst Ratings: 0 Sell Rating(s)
3 Hold Rating(s)
8 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
7 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
3 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
BCRX Consensus Price Target: $11.38$9.86$9.07$8.25
BCRX Price Target Upside: 4.17% upside92.07% upside121.64% upside123.17% upside

BioCryst Pharmaceuticals (NASDAQ:BCRX) Consensus Price Target History

Average Share Price and Price Target by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

BioCryst Pharmaceuticals (NASDAQ:BCRX) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
3/1/2021CowenInitiated CoverageOutperform$16.00Low
2/26/2021BarclaysBoost Price TargetOverweight$9.00 ➝ $13.00Low
1/22/2021Royal Bank of CanadaBoost Price TargetSector Perform$7.00 ➝ $9.00High
12/7/2020HC WainwrightBoost Price TargetBuy$13.00 ➝ $14.00High
11/23/2020Evercore ISIInitiated CoverageOutperform$12.00High
10/4/2020Bank of AmericaReiterated RatingBuy$6.00High
9/29/2020JPMorgan Chase & Co.Initiated CoverageOverweightMedium
6/26/2020JMP SecuritiesBoost Price TargetOutperform$10.00 ➝ $11.00High
6/16/2020BTIG ResearchInitiated CoverageNeutralHigh
6/8/2020Piper SandlerReiterated RatingBuy$10.00Medium
5/6/2020Needham & Company LLCReiterated RatingHoldLow
5/22/2019Jefferies Financial GroupLower Price TargetBuy$13.00 ➝ $8.00High
4/22/2019Piper Jaffray CompaniesSet Price TargetBuy$15.00Medium
6/28/2018Seaport Global SecuritiesReiterated RatingNeutralLow
(Data available from 3/5/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)
This page was last updated on 3/5/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.